Issue Date: April 12, 2010
Arsenic Binding Defeats Leukemia
Arsenic has been used for centuries as a medical treatment, and in the form of arsenic trioxide, it’s currently a highly effective FDA-approved treatment for a type of leukemia. Chinese researchers led by Sai-Juan Chen and Zhu Chen of Shanghai Jiao Tong University School of Medicine have now determined that As2O3 works by binding to a cysteine-rich region of a key protein found in promyelocytic leukemia patients, initiating a chain of events . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society